Searched for
Q LINE BIOTECH
Mutual funds added these 4 new stocks to their portfolios in May. Check detailsMutual funds introduced four new stocks into their portfolios in May, according to Prime Database disclosures. Afcom Holdings saw the highe...- Sunil Singhania-backed Abakkus Small Cap Fund adds 3 new stocks, increases stake in HDFC Bank, SBI and 49 othersSunil Singhania's Abakkus Small Cap Fund added three new stocks in May, including Tanla Platforms and Intellect Design Arena. The fund also...
- Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
- IPO calendar: 3 companies set to launch public offers this week; check detailsThis comes as markets continue to witness sharp downswings and muted recoveries, with oil prices remaining elevated amid the seesaw politic...
- Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj ChinthalapellyDheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...
- Delhivery, Blackbuck Q2 results; MoEngage's $100 million roundTransportation players Delhivery and Blackbuck declared their financials for the second quarter today. This and more in today's ETtech Top ...
- US Stock market future today: Dow, S&P 500, Nasdaq slip as Fed takes the wheel — earnings, tech turbulence & global tensions shake investor confidenceUS Stock market future today reflects a cautious mood as Wall Street stalls amid fears of U.S. involvement in the growing Israel-Iran confl...
- From engineering to Wall Street: Ankit Aggarwal on building a career at the intersection of science and financeAnkit Aggarwal, with a decade of experience in global capital markets, shares his journey from IIT Bombay to J.P. Morgan, highlighting his ...
- Concord Biotech shares tumble 16% after weak Q3 earningsConcord Biotech shares fell 16% to Rs 1,777.7 after the company reported a 2.1% YoY decline in Q3 FY25 net profit to Rs 75.92 crore, despit...
- Syngene International Q2 Results: Net profit drops 9% to Rs 106 croreSyngene International, the contract research and manufacturing services arm of Biocon reported a 9% year-on-year (YoY) drop in net profit t...
- Syngene Q1 Results: Net profit drops 19% to Rs 76 croreSyngene International, the contract research and manufacturing services arm of Biocon, reported 19% year-on-year (YoY) drop in net profit t...
- Concord Biotech stock slips over 5% after Rs 519 crore worth of shares change handsShares of Concord Biotech fell 5.3% on BSE due to a large block deal where Ontario Inc. sold a 3.4% stake at a discount, impacting stock pe...
- Expect Syngene revenue to grow from high single digits to low double digits next year: Jonathan HuntJonathan Hunt detailed the investment strategy of Syngene International, facing revenue growth challenges due to US biotech funding delays....
- We expect mid-teen growth for full year despite softening of US biotech segment: Jonathan Hunt, SyngeneI think that restructuring and that evolution of becoming not only a bigger business, but one that is well balanced between both the manufa...
- IPO mart looking up: Rossari set to test waters; few others may followRossari would be the first IPO after SBI Cards & Payments IPO hit the market in early March.
- Add Syngene International, target Rs 650: Yes SecuritiesAdd Syngene International at a price target of Rs 650.
- Strides Arcolab sells 25.1% stake in arm to GMS Holdings; stock upStrides has so far invested $16.9 million in Stelis. The duo will invest $61.9 million taking total equity investment in Stelis to $78.8 mi...
- Zydus eyes acquisitions to turn consumer arm into Rs 500-cr companyZydus Cadila Group, is looking for an exponential grown of its consumer product subsidiary, Zydus Wellness Ltd (ZWL).
Load More
